Monthly monitoring and detection of new adverse reactions and possible interactions by regulatory agencies is an essential process to keep healthcare professionals updated on emerging risks associated with certain drugs. These reports allow a continuous evaluation of the benefit-risk ratio of existing treatments, facilitating adjustments in prescribing guidelines and a more informed management by physicians.
Early identification and reporting of new adverse reactions, interactions and precautions are critical to ensure the safety and well-being of patients. These reports provide critical information that can influence prescribing decisions, allowing healthcare professionals to weigh the risks and benefits of a specific treatment for each individual patient.
By having access to these reports on a regular and timely basis, healthcare professionals can adapt their clinical practices and adjust treatment strategies accordingly. This continuous monitoring and updating process contributes to safer and more effective medical care, while fostering greater confidence in the medical community regarding pharmacotherapy management.
EN 
ES